retatrutide benefits besides weight loss with as compared to currently licenced obesity Retatrutide Before and After: Doctor

October 2025 : The Wegovy warning label was updated to include Severe Gastrointestinal Adverse Reactions in the WARNINGS AND PRECAUTIONS section

Phase Therapeutic range Weeks 13-16 Weekly Dose 9 mg Notes Step to 9 mg or hold at 6 mg

Eur J Heart Fail 22:14951503 Seferovi PM, Fragasso G, Petrie M, Mullens W, Ferrari R, Thum T, Bauersachs J, Anker SD, Ray R, avuolu Y, Polovina M, Metra M, Ambrosio G, Prasad K, Seferovi J, Jhund PS, Dattilo G, elutkiene J, Piepoli M, Moura B, Chioncel O, Ben Gal T, Heymans S, Jaarsma T, Hill L, Lopatin Y, Lyon AR, Ponikowski P, Lainak M, Jankowska E, Mueller C, Cosentino F, Lund LH, Filippatos GS, Ruschitzka F, Coats AJS, Rosano GMC (2020) Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure

However, it is uncertain whether those actions directly contribute to the nephroprotective effects of GLP-1 receptor agonists